Carri Duncan

Carri Duncan, Ph.D., is a seasoned professional with extensive experience in the healthcare and life sciences sectors. Currently serving as a Senior Advisor at FGS Global and a Non-Executive Director at eureKING, Carri is focused on biomanufacturing innovation. Previous roles include Partner at Brunswick Group, where expertise was applied in healthcare consulting, and Partner and Founder of Karaktero, a corporate finance advisory firm. Carri's background features significant leadership positions, including VP of Corporate Development at Celyad Oncology, Senior Investor Relations Manager at Bayer, and Specialist Consultant at Egon Zehnder International. Carri began a career in research as a Scientist at Novartis after earning a Ph.D. in Neuroscience from ETH Zürich, complemented by a Master of Science in Genetics from Michigan State University.